A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.
The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...
Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) ...
After a heart attack, aging adults face double or triple the risk of life-threatening complications – like a debilitating ...
Introduction ST-elevation myocardial infarction (STEMI ... All the patients have been included in the Galician Acute Myocardial Infarction Registry (Registro Gallego de Infarto Agudo de Miocardio ...
Introduction: Hypoxic liver injury (HLI) and Killip classification are poor prognostic factors in patients with ST-segment elevation myocardial infarction (STEMI). This study investigates the ...
The aim of this study was to assess whether this post-extrasystolic ST segment and T wave variation (PEST ... In patients with heart disease such as survivors of acute myocardial infarction, risk ...
Successful reperfusion following ST-segment elevation myocardial infarction ... However, only a minority of acute myocardial infarction (MI) patients present in such "ideal circumstances." ...
Serum Extracellular Vesicle-derived microRNA Profiles in Patients with ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Cardiovascular Innovations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback